Development of Strategies to Manipulate ErbB Receptor Heterodimerization from a Quantitative Analysis of Receptor/Ligand Relationships

Abstract

The four erbB receptor tyrosine kinases are activated by dimerization upon binding their cognate ligands, which include epidermal growth factor (EGF) and the neuregulins (NRG's). Each receptor has a large extracellular ligand-binding domain, a single transmembrane domain, and an intracellular tyrosine kinase/regulatory domain. More than 12 different erbB ligands exist, which are thought to activate erbB receptors by inducing receptor hetero- as well as homo-dimerization. A view has emerged in which each ligand induces a specific set of receptor homo- and hetero-dimers, which yield characteristic biological responses. We have set about quantitating the ability of erbB ligands to induce specific erbB receptor dimer using purified isolated receptor extracellular domains.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 1999
Accession Number
ADB258643

Entities

People

  • Mark A. Lemmon

Organizations

  • University of Pennsylvania

Tags

DTIC Thesaurus Topics

  • Amino Acids
  • Biomedical Research
  • Breast Cancer
  • Cell Line
  • Cells
  • Chemistry
  • Fungi
  • Growth Factors
  • Light Scattering
  • Materials
  • Molecules
  • Neoplasms
  • Proteins
  • Scattering
  • Standards
  • Surface Plasmon Resonance
  • X Rays

Fields of Study

  • Biology
  • Chemistry

Readers

  • Breast cancer cell signaling and growth regulation.